Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2882362 | The Annals of Thoracic Surgery | 2007 | 9 Pages |
Abstract
There does not appear to be an indication for routine antithrombotic management. The study supports the potential use of antithrombotic therapy for comorbidities of preoperative cerebrovascular accident and concomitant CABG but not atrial fibrillation, left ventricular dysfunction, or elderly age greater than 70 years. Vascular burden and advanced age are likely contributing factors to these independent predictors. There may still be a need for, or at least consideration of, a randomized trial for AVR with bioprostheses.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
W.R. Eric MD, Susan D. MD, Peter MD, Majdi Abdel MD, Jian MD, Guy J. MD, James G. MD, Michael T. MD, Anson MD, Eva MS,